Get Premium to unlock powerful stock data

Ghost Tree Capital, LLC Buys Ascendis Pharma A/S, Sarepta Therapeutics Inc, Merus NV, Sells Iovance Biotherapeutics Inc, Xenon Pharmaceuticals Inc, Allakos Inc

Author's Avatar
Feb 18, 2022
Article's Main Image
New York, NY, based Investment company Ghost Tree Capital, LLC (Current Portfolio) buys Ascendis Pharma A/S, Sarepta Therapeutics Inc, Merus NV, Apellis Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, sells Iovance Biotherapeutics Inc, Xenon Pharmaceuticals Inc, Allakos Inc, GH Research PLC, Aldeyra Therapeutics Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Ghost Tree Capital, LLC. As of 2021Q4, Ghost Tree Capital, LLC owns 46 stocks with a total value of $279 million. These are the details of the buys and sells.

For the details of Ghost Tree Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ghost+tree+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Ghost Tree Capital, LLC
  1. Ascendis Pharma A/S (ASND) - 190,000 shares, 9.16% of the total portfolio. Shares added by 58.33%
  2. Apellis Pharmaceuticals Inc (APLS) - 325,000 shares, 5.51% of the total portfolio. Shares added by 62.50%
  3. Cogent Biosciences Inc (COGT) - 1,700,000 shares, 5.23% of the total portfolio. Shares added by 13.33%
  4. Celldex Therapeutics Inc (CLDX) - 350,000 shares, 4.85% of the total portfolio. Shares added by 37.25%
  5. RAPT Therapeutics Inc (RAPT) - 350,000 shares, 4.61% of the total portfolio. Shares added by 40.00%
New Purchase: Sarepta Therapeutics Inc (SRPT)

Ghost Tree Capital, LLC initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $77.28 and $99.42, with an estimated average price of $85.35. The stock is now traded at around $76.640000. The impact to a portfolio due to this purchase was 3.23%. The holding were 100,000 shares as of 2021-12-31.

New Purchase: Alnylam Pharmaceuticals Inc (ALNY)

Ghost Tree Capital, LLC initiated holding in Alnylam Pharmaceuticals Inc. The purchase prices were between $159.56 and $209.29, with an estimated average price of $185.93. The stock is now traded at around $149.950000. The impact to a portfolio due to this purchase was 1.82%. The holding were 30,000 shares as of 2021-12-31.

New Purchase: Aadi Bioscience Inc (AADI)

Ghost Tree Capital, LLC initiated holding in Aadi Bioscience Inc. The purchase prices were between $19.32 and $29.02, with an estimated average price of $25.03. The stock is now traded at around $18.100000. The impact to a portfolio due to this purchase was 1.73%. The holding were 200,000 shares as of 2021-12-31.

New Purchase: Kezar Life Sciences Inc (KZR)

Ghost Tree Capital, LLC initiated holding in Kezar Life Sciences Inc. The purchase prices were between $7.44 and $16.72, with an estimated average price of $11.43. The stock is now traded at around $14.420000. The impact to a portfolio due to this purchase was 1.5%. The holding were 250,000 shares as of 2021-12-31.

New Purchase: Pyxis Oncology Inc (PYXS)

Ghost Tree Capital, LLC initiated holding in Pyxis Oncology Inc. The purchase prices were between $8.39 and $13.64, with an estimated average price of $11.44. The stock is now traded at around $7.390000. The impact to a portfolio due to this purchase was 1.16%. The holding were 295,000 shares as of 2021-12-31.

New Purchase: Design Therapeutics Inc (DSGN)

Ghost Tree Capital, LLC initiated holding in Design Therapeutics Inc. The purchase prices were between $13.64 and $21.41, with an estimated average price of $17.25. The stock is now traded at around $14.110000. The impact to a portfolio due to this purchase was 1.04%. The holding were 135,000 shares as of 2021-12-31.

Added: Ascendis Pharma A/S (ASND)

Ghost Tree Capital, LLC added to a holding in Ascendis Pharma A/S by 58.33%. The purchase prices were between $127.1 and $169.66, with an estimated average price of $148.37. The stock is now traded at around $114.740000. The impact to a portfolio due to this purchase was 3.37%. The holding were 190,000 shares as of 2021-12-31.

Added: Merus NV (MRUS)

Ghost Tree Capital, LLC added to a holding in Merus NV by 366.67%. The purchase prices were between $20 and $32.29, with an estimated average price of $28.39. The stock is now traded at around $26.490000. The impact to a portfolio due to this purchase was 3.14%. The holding were 350,000 shares as of 2021-12-31.

Added: Apellis Pharmaceuticals Inc (APLS)

Ghost Tree Capital, LLC added to a holding in Apellis Pharmaceuticals Inc by 62.50%. The purchase prices were between $30.74 and $49.16, with an estimated average price of $39.7. The stock is now traded at around $44.970000. The impact to a portfolio due to this purchase was 2.12%. The holding were 325,000 shares as of 2021-12-31.

Added: Celldex Therapeutics Inc (CLDX)

Ghost Tree Capital, LLC added to a holding in Celldex Therapeutics Inc by 37.25%. The purchase prices were between $35.68 and $56.27, with an estimated average price of $43.33. The stock is now traded at around $30.250000. The impact to a portfolio due to this purchase was 1.32%. The holding were 350,000 shares as of 2021-12-31.

Added: RAPT Therapeutics Inc (RAPT)

Ghost Tree Capital, LLC added to a holding in RAPT Therapeutics Inc by 40.00%. The purchase prices were between $29.5 and $39.5, with an estimated average price of $33.47. The stock is now traded at around $20.630000. The impact to a portfolio due to this purchase was 1.32%. The holding were 350,000 shares as of 2021-12-31.

Added: Viridian Therapeutics Inc (VRDN)

Ghost Tree Capital, LLC added to a holding in Viridian Therapeutics Inc by 42.86%. The purchase prices were between $15.65 and $21.5, with an estimated average price of $18.72. The stock is now traded at around $20.200000. The impact to a portfolio due to this purchase was 1.06%. The holding were 500,000 shares as of 2021-12-31.

Sold Out: Iovance Biotherapeutics Inc (IOVA)

Ghost Tree Capital, LLC sold out a holding in Iovance Biotherapeutics Inc. The sale prices were between $16.55 and $27.63, with an estimated average price of $21.87.

Sold Out: Allakos Inc (ALLK)

Ghost Tree Capital, LLC sold out a holding in Allakos Inc. The sale prices were between $8.55 and $111.89, with an estimated average price of $80.43.

Sold Out: Aldeyra Therapeutics Inc (ALDX)

Ghost Tree Capital, LLC sold out a holding in Aldeyra Therapeutics Inc. The sale prices were between $3.5 and $9.63, with an estimated average price of $7.56.

Sold Out: Atea Pharmaceuticals Inc (AVIR)

Ghost Tree Capital, LLC sold out a holding in Atea Pharmaceuticals Inc. The sale prices were between $7.67 and $44.59, with an estimated average price of $14.96.

Sold Out: Helix Acquisition Corp (HLXA)

Ghost Tree Capital, LLC sold out a holding in Helix Acquisition Corp. The sale prices were between $9.86 and $10.15, with an estimated average price of $9.93.

Sold Out: Praxis Precision Medicines Inc (PRAX)

Ghost Tree Capital, LLC sold out a holding in Praxis Precision Medicines Inc. The sale prices were between $16.76 and $22.99, with an estimated average price of $19.56.



Here is the complete portfolio of Ghost Tree Capital, LLC. Also check out:

1. Ghost Tree Capital, LLC's Undervalued Stocks
2. Ghost Tree Capital, LLC's Top Growth Companies, and
3. Ghost Tree Capital, LLC's High Yield stocks
4. Stocks that Ghost Tree Capital, LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus